Sentence examples for institutional phase from inspiring English sources

Now we're in the institutional phase where we know there's a problem and we have got to find the solutions".

They postulate that the real rehabilitation process just begins after the institutional phase is completed.

Initial institutional Phase II trials of this combination have not demonstrated superior time-to-progression or OS than either treatment alone, but some patients have durable tumor control.

Twenty patients in this cohort were enrolled on an institutional phase II study evaluating the combination of capecitabine, oxaliplatin, cetuximab and bevacizumab in the front line metastatic setting (between 2006 and 2008).

In the clinical arena bortezomib as a single agent showed limited clinical efficacy (objective response) in two single institutional phase II clinical trials for patients with previously treated metastatic breast cancers (MBC) [ 11, 12].

Of these, 100 patients had been treated in the past within a preliminary validation phase I study [ 11, 12] and 440 patients are currently in an institutional phase III ongoing randomized clinical trial, in which 21 Gy ELIOT (prescribed at 90% isodose) is prospectively compared with external postoperative fractionated radiotherapy (PFR) including elective treatment of the whole breast.

Only large, multi-institutional phase III trials can determine whether combined modality therapy is superior to resection alone.

This multi-institutional phase I/II trial explored patient-assessed tolerance of increasingly hypofractionated (HPFX) radiation for low/intermediate risk prostate cancer.

Multi-institutional phase III investigation is currently underway to evaluate the impact of allogeneic prostate GVAX® cellular immunotherapy on time to progression and overall survival in hormone refractory prostate cancer.

A multi-institutional phase II trial was conducted to evaluate the efficacy and safety of PKCβ inhibitor enzastaurin in persistent or recurrent EOC/PPC and to explore potential prognostic and predictive biomarkers.

We describe herein the rationale/study design for a multi-institutional, phase II randomized study to evaluate either daily subcutaneous or intravenous bolus infusions of amifostine in patients with non-small cell lung cancer who receive standard fractionated thoracic radiation therapy concurrently with weekly paclitaxel and carboplatin chemotherapy.